Auxilium Pharmaceuticals

Philadelphia, United States Founded: 1999 • Age: 27 yrs Listed Acquired By Endo International
Developer of therapeutics and drug-device combinations for urology and sexual health

About Auxilium Pharmaceuticals

Auxilium Pharmaceuticals is a Healthcare company based in Philadelphia (United States) founded in 1999, and was acquired by Endo International in October 2014. Developer of therapeutics and drug-device combinations for urology and sexual health. Auxilium Pharmaceuticals has raised $43 million across 1 funding round from investors including Credit Suisse, Endo International and Schroders. Auxilium Pharmaceuticals has completed 1 acquisition, including Actient Pharma. Its focus areas include Life Sciences, Women Health, Drugs and Sustainability Tech. Its competitors include Agile Therapeutics, Xanodyne Pharmaceuticals and Microchips Biotech; 3 of its 3 listed competitors have raised funding.

Company details

Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.

Key Metrics

Funding Insights of Auxilium Pharmaceuticals

Auxilium Pharmaceuticals has successfully raised a total of $43M through 1 strategic funding round. The most recent funding activity was a Series D round of $43 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $43M
  • Total Rounds 1
  • Last Round Series D β€” $43M
  • First Round $43M

    (Nov 2003)

  • Investors Count 6

All 1 funding rounds of Auxilium Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2003$43MSeries D––
Valuation history

7 investors in total: 7 institutional.

Investors in Auxilium Pharmaceuticals

Auxilium Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Endo International and Schroders.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
bbbiotechventures.com
scppartners.com
Global financial advisory services are provided by the firm.
lehman.comNew York, United States
Investment management and wealth management services are provided to clients.
1804schroders.comLondon, United Kingdom
Wealth management, asset management, and investment banking services are offered.
1856credit-suisse.comZurich, Switzerland
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines
1997endo.comMalvern, United States
Premium access

Investor details for Auxilium Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Auxilium Pharmaceuticals

Auxilium Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actient Pharma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Banned-substance-free sports nutrition supplements are manufactured for athletes and bodybuilders.
actientpharma.comChicago, United States2009Apr 2013$585M
Premium access

Complete acquisition details for Auxilium Pharmaceuticals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Auxilium Pharmaceuticals

5 dated milestones of Auxilium Pharmaceuticals across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Auxilium Pharmaceuticals is founded.
  2. Funding First funding round of $43.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Actient Pharma.
  5. Exit Acquired by Endo International.

Competitors of Auxilium Pharmaceuticals

Auxilium Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Agile Therapeutics, Xanodyne Pharmaceuticals and Microchips Biotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
agiletherapeutics.com1997Princeton, United States$123.06M
Therapeutics for women's healthcare are developed and offered.
xanodyne.com2001Florence, United States$175.78M6
Developer of drugs for women's health and pain management
microchipsbiotech.com1999Lexington, United States$118.61M10
Microchip implants for wireless drug delivery are developed.
Premium access

Detailed competitors of Auxilium Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Auxilium Pharmaceuticals

Websites that share an audience with Auxilium Pharmaceuticals (auxilium.com).

Similar websites

Websites whose visitors overlap most with Auxilium Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
merck.com
100%
656.8K#78,842View details
bms.com
96%
809.8K#67,210View details
pfizer.com
95%
1.9M#24,984View details
auxilium-inc.com
76%
1.1K#12,796,148View details
gsk.com
69%
1.3M#56,834View details

Top companies in Women's Health & Fertility

3 companies that operate in the same segment as Auxilium Pharmaceuticals (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 123.06 MUSD 19.59 M
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M861
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Auxilium Pharmaceuticals

Premium access

Complete news archive for Auxilium Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Auxilium Pharmaceuticals

Auxilium Pharmaceuticals was founded in 1999 and raised its 1st funding round 4 years after it was founded.

Auxilium Pharmaceuticals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Auxilium Pharmaceuticals is a funded company, having raised a total of $43M across 1 funding round to date. The company's 1st funding round was a Series D of $43M, raised on Nov 2003.

Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.

Auxilium Pharmaceuticals's top competitors include Agile Therapeutics, Microchips Biotech and Xanodyne Pharmaceuticals.

Auxilium Pharmaceuticals has made 1 acquisition, including Actient Pharma.

Auxilium Pharmaceuticals has 7 investors. Key investors include Credit Suisse, Endo International, Schroders, Orbimed, and BB Biotech Ventures.

Yes. Auxilium Pharmaceuticals was acquired by Endo International in October 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available